Dongwei Dou
No. 1 Jianshe East Road
Zhengzhou, 450000, China
Zhengzhou, 450000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
The development of a business intelligence system for analyzing online appointment behaviors: A case study at the first affiliated hospital of Zhengzhou University.
Journal: Digital health
Published: May 13, 2025
A serialization method for digitizing the image-based medical laboratory report.
Journal: Digital health
Published: November 22, 2024
Retraction Note: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer.
Journal: Cell death & disease
Published: November 10, 2023
Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation.
Journal: Molecular cancer
Published: July 12, 2022
miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4/PI3K-AKT axis and predicts poor outcome.
Journal: Cell death & disease
Published: November 29, 2020
Exosomal long noncoding RNA AGAP2-AS1 regulates trastuzumab resistance via inducing autophagy in breast cancer.
Journal: American journal of cancer research
Published: October 08, 2020
Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.
Journal: Molecular oncology
Published: July 29, 2020
CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis.
Journal: Cancer cell international
Published: May 25, 2020
The Application of Mobile Telehealth System to Facilitate Patient Information Presentation and Case Discussion.
Journal: Telemedicine journal and e-health : the official journal of the American Telemedicine Association
Published: April 17, 2020
Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway.
Journal: Frontiers in immunology
Published: March 19, 2020
TRIM3 inhibits P53 signaling in breast cancer cells.
Journal: Cancer cell international
Published: February 02, 2020
Last Updated: 09/26/2026